When your team needs to assess a competitive landscape before a board meeting, compare trial designs across a dozen assets, or screen 200 pipeline candidates to a shortlist of 10, Maven Bio turns those multi-day projects into structured, evidence-backed deliverables in minutes.
Maven Bio is an AI research and analysis platform purpose-built for life sciences. It combines a curated biomedical ontology, continuously updated primary source documents, and an AI agent that plans, executes, and delivers cited analyses.
Platform Capabilities
Capability | What it does | When to use it |
AI Research Agent | Plans and executes structured analysis from a single prompt. Delivers tables, reports, spreadsheets, presentations, and charts with full citations. | End-to-end analysis: landscapes, cross-trial comparisons, asset deep dives, opportunity assessments, meeting prep |
Smart Tables | Structured data tables with AI-powered columns that research each row independently. Build via search, import, or blank table. | Building and enriching lists of drugs, trials, companies, or indications with custom criteria |
Report Builder | Multi-section narrative reports backed by deep research. Define objectives, sections, and attach context to guide the analysis. | Indication overviews, asset dossiers, competitive briefings, or any analysis that requires narrative depth with citations |
Watchlists | Filterable event feeds for the drugs, trials, and companies you track. Configurable email digests with AI-generated summaries. | Monitoring regulatory catalysts, trial updates, press releases, and competitive moves across your coverage universe |
Projects | Organized workspaces where tables, reports, agent tasks, and files live together. Shareable with teammates at viewer, contributor, or owner levels. | Grouping research by client engagement, therapeutic area, asset, or strategic initiative for team collaboration |
Workflows | Reusable analysis templates that define methodology, deliverables, and quality criteria. Use Maven Bio's built-in workflows or create your own. | Standardizing recurring analyses (landscapes, screens, TPPs) across your team for consistent, reproducible output |
Biomedical Ontology
Every capability draws on Maven Bio's expert-curated ontologies, which map relationships across entities and power high-precision analysis.
Entity Type | Coverage | Update Frequency |
Drug Products | ~70K candidate and marketed therapeutics (global) | Daily |
Clinical Studies | ~300K interventional studies linked to drugs, across 21 trial registries | Daily |
Companies | ~30K biopharma companies linked to drugs and trials | Daily |
Indications | ~3.5K clinically relevant conditions | Quarterly |
Mechanisms | ~50K mechanisms of action | Quarterly |
Targets | ~10K biological targets | Quarterly |
Data Sources
Maven Bio continuously ingests primary source documents and maps them to ontology entities, enabling precise, citation-backed analysis.
Source | Coverage |
Press Releases | Continuously refreshed corporate news |
Company Websites | Official sites including PDFs and investor presentations, refreshed multiple times per week |
Conference Abstracts | Major global conferences across oncology, immunology, neurology, rare disease, and more |
Journal Articles | Full-text for open-access, abstracts for closed. Refreshed hourly |
SEC Filings | Full coverage across tracked companies, refreshed continuously |
Earnings Call Transcripts | Full-text transcripts, refreshed daily |
Deals and Partnerships | Licensing, M&A, and collaboration transactions, updated daily |
Financial Metrics | Market cap, cash runway, and capital market indicators for publicly traded companies |
Web Search | On-demand queries to supplement primary sources for specific research tasks |
What you can do next
If you are getting started, the Quick Reference Guide walks through each capability with practical tips. To dive into a specific feature, start with Understanding the AI Research Agent or Creating a Table via Search.